Parkinson's Disease Posts - Page 15 of 17 on Medivizor
Navigation Menu

Parkinson’s Disease Posts on Medivizor

Evaluating the side effects and impact of medical cannabis on Parkinson’s disease symptoms

Evaluating the side effects and impact of medical cannabis on Parkinson’s disease symptoms

Posted by on Sep 14, 2018 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the side effects and impact of medical cannabis on the symptoms of Parkinson’s disease (PD). This study concluded that medical cannabis improved PD symptoms and did not cause major side effects. Some background PD is a progressive disease caused by loss of brain cells that make dopamine. Dopamine is a chemical...

Read More

Low vitamin D affects the sense of smell of patients with Parkinson´s disease

Posted by on Sep 13, 2018 in Parkinson's Disease | 0 comments

In a nutshell This study investigated if low levels of vitamin D are associated with symptoms in the sense of smell of patients with Parkinson´s disease (PD). Researchers suggested that low levels of vitamin D are associated with a dysfunction in the sense of smell.   Some background PD is caused by the loss of certain brain cells. The...

Read More

Physical exercise prevents falls in patients with Parkinson´s disease

Physical exercise prevents falls in patients with Parkinson´s disease

Posted by on Sep 6, 2018 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the effects of physical exercise in the improvement of gait and balance and reduction of falls in patients with Parkinson´s disease (PD). Researchers suggested that physical training improves gait ability and balance in these patients. Some background Falls are common in patients with PD which can lead to...

Read More

Clinical Trials Today

Clinical Trials Today

Posted by on Aug 26, 2018 in Benign prostatic hyperplasia, Blog, Breast cancer, Colorectal cancer, Coronary artery disease, Diabetes mellitus, Erectile dysfunction, Hodgkin's lymphoma, Hypertension, Infertility, Kidney stones, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Nocturia, Non-Hodgkin lymphoma, Overactive bladder, Parkinson's Disease, Prostate cancer, Rheumatoid Arthritis, Stroke, Urinary incontinence, Urinary tract infection | 11 comments

Prior to the 20th century, most people lived about 47 years in the developed world because of infectious diseases. In 1940, the first use of penicillin to treat infectious diseases occurred and penicillin became available in 1945 to the general public. Science and research conducted throughout the 1950s, 60s, and 70s, created more antibiotics so that life...

Read More

Non-ergot dopamine agonists do not increase the risk of heart failure in patients with Parkinson´s disease

Posted by on Aug 20, 2018 in Parkinson's Disease | 0 comments

In a nutshell This study investigated whether non-ergot dopamine agonists (DA) are associated with heart failure. Researchers suggested that DA therapy is not related to heart disease. Some background Levodopa is a main treatment option for Parkinson’s disease. Long-term use of levodopa, however, can lead to motor complications. Ergot and...

Read More

Evaluating rasagiline as add-on therapy in patients with Parkinson’s disease

Evaluating rasagiline as add-on therapy in patients with Parkinson’s disease

Posted by on Aug 13, 2018 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the safety and effectiveness of rasagiline (Azilect) in patients with Parkinson’s disease (PD) and wearing-off effects (motor symptoms worsen as levodopa wears off before the next dose is taken). This study concluded that rasagiline improved symptoms and quality of life in these patients. Some background PD is...

Read More

Evaluating apomorphine infusion for patients with Parkinson’s disease and motor fluctuations

Evaluating apomorphine infusion for patients with Parkinson’s disease and motor fluctuations

Posted by on Aug 13, 2018 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the safety and effectiveness of apomorphine (Apo-Go) for the treatment of motor fluctuations in patients with Parkinson’s disease (PD). The conclusion of the study was that this treatment significantly reduced “off” time (poor motor performance during periods when medications for PD have no effect) for...

Read More

Surgery/deep brain stimulation and medical therapy improves the quality of life of patients with Parkinson’s disease

Posted by on Aug 10, 2018 in Parkinson's Disease | 0 comments

In a nutshell This study investigated whether surgery and medical therapy increase the quality of life of patients with advanced Parkinson´s disease (PD). Researchers suggested that surgery combined with medical therapy was associated with improved quality of life for these patients, when compared to therapy alone.   Some background PD is...

Read More